22 Results for "

GABA_A receptor ligand

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "GABA_A receptor ligand" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-113329
CAS No.: 543-18-0
Purity:  ≥98.0%
Synonyms: Taurocyamine
Guanidinoethyl sulfonate (Taurocyamine) is an orally available, blood-brain permeable competitive inhibitor of taurine transporters and a competitive antagonist of glycine receptors (GlyR) (IC50=565 μM). Guanidinoethyl sulfonate has both weak agonist and antagonist effects on GABAA receptors. Guanidinoethyl sulfonate inhibits taurine transmembrane transport and competitively binds to the GlyR ligand binding domain, thereby blocking glycine-mediated chloride influx, and may regulate brain pH to exert neuroprotective effects. Guanidinoethyl sulfonate can be used for neuroprotection studies of ischemic brain injury .
loading...
    loading...
Cat. No.: HY-W013150
CAS No.: 82626-01-5
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Alpidem, an anxiolytic agent, is an orally active and brain-penetrant GABAA receptor ligand, binds to α1β2γ2 subunit-containing GABAA receptors (IC50 of 17 nM) over α5β2γ2 subunit-containing GABAA receptors (IC50 of >10 μM). Alpidem modulates calcium-induced mitochondrial permeability transition, induces glutathione depletion and hepatocyte necrosis, potentiates TNF-α toxicity, inhibits marble-burying and locomotor activity, enhances stressed rodent feeding behavior, and exerts anticonvulsant effects. Alpidem can be used for the research of anxiety, anxiety disorders, and convulsions .
loading...
    loading...
Cat. No.: HY-105042
CAS No.: 129954-34-3
Synonyms: Selanc; TP-7
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Selank (Selanc; TP-7) is a GABAA receptor modulator with anxiolytic activity. Selank allosterically modulates the specific binding of GABA to GABAA receptors and alters the affinity of endogenous ligands for these receptors. Selank reduces elevated anxiety levels, attenuates stress-induced exacerbation of anxiety, and produces a synergistic anxiolytic effect with diazepam. Selank can be used in the research of anxiety disorders .
loading...
    loading...
Cat. No.: HY-124467
CAS No.: 39080-67-6
Synonyms: Ro 07-4065
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Difludiazepam (Ro 07-4065), a benzodiazepine derivative, is a GABAA receptor ligand with an IC50 of 4.1 nM. Difludiazepam binds to an allosteric site on the GABAA receptor to potentiate the receptor's response to GABA, reducing neuron excitability. Difludiazepam contains halogenated groups at the ortho position of its phenyl ring .
loading...
    loading...
Cat. No.: HY-120874
CAS No.: 1614245-70-3
Purity:  99.29%
Synonyms: PF-06372865; CVL-865
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Darigabat (PF-06372865) is an orally active, α2/α3/α5 subtype-selective GABAA positive allosteric modulator (PAM). Darigabat is a high affinity ligand at GABAA receptors containing α1/α2/α3/α5 subunits (Kis of 2.9 nM, 21 nM, 134 nM for α2, α1 PAM, α2 PAM, respectively), with low affinity for α4/α6 subunits. Darigabat can across the blood-brain barrier (BBB). Darigabat has anxiolytic activity and has the potential for epilepsy .
loading...
    loading...
Cat. No.: HY-105042A
Purity:  99.90%
Synonyms: Selanc diacetate; TP-7 diacetate
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Selank diacetate (Selanc diacetate; TP-7 diacetate) is a GABAA receptor modulator with anxiolytic activity. Selank diacetate allosterically modulates the specific binding of GABA to GABAA receptors and alters the affinity of endogenous ligands for these receptors. Selank diacetate reduces elevated anxiety levels, attenuates stress-induced exacerbation of anxiety, and produces a synergistic anxiolytic effect with diazepam. Selank diacetate can be used in the research of anxiety disorders .
loading...
    loading...
Cat. No.: HY-103511
CAS No.: 185391-33-7
Purity:  99.66%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

TCS1105 is a benzodiazepine ligand with agonist for α2-subunit containing GABAA receptors and antagonist for α1-subunit containing GABAA receptors. TCS1105 reduces anxiety-like behavior in mice. TCS1105 enhances offensive behavior and social dominance. TCS1105 blocks Sema3A induced AGC (axonal growth cones) collapse in a concentration-dependent fashion .
loading...
    loading...
Cat. No.: HY-113329R
CAS No.: 543-18-0
Synonyms: Taurocyamine (Standard)
Guanidinoethyl sulfonate (Standard) is the analytical standard of Guanidinoethyl sulfonate. This product is intended for research and analytical applications. Guanidinoethyl sulfonate is an orally available, blood-brain permeable competitive inhibitor of taurine transporters and a competitive antagonist of glycine receptors (GlyR) (IC50=565 μM). Guanidinoethyl sulfonate has both weak agonist and antagonist effects on GABAA receptors. Guanidinoethyl sulfonate inhibits taurine transmembrane transport and competitively binds to the GlyR ligand binding domain, thereby blocking glycine-mediated chloride influx, and may regulate brain pH to exert neuroprotective effects. Guanidinoethyl sulfonate can be used for neuroprotection studies of ischemic brain injury .
loading...
    loading...
Cat. No.: HY-133486
CAS No.: 1571-87-5
Purity:  98.45%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor agent 1 is a high affinity ligand for GABAA receptor, with potent anticonvulsant activity .
loading...
    loading...
Cat. No.: HY-P5964A
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

K1 peptide TFA is a high-affinity peptide ligand for GABAA receptor-associated protein (GABARAP) .
loading...
    loading...
Cat. No.: HY-100686
CAS No.: 152273-12-6
Purity:  99.85%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

U93631 is a GABAA receptor inhibitor targeting the picrotoxin (HY-101391) site, which exhibits higher inhibitory potency in receptors lacking α subunits. U93631 blocks GABA-induced chloride currents, exerts a mild initial stimulatory effect on activated currents, but its activity decreases in β2T246F mutant receptors. U93631 can serve as a ligand for the convulsant site of GABAA receptors in relevant studies .
loading...
    loading...
Cat. No.: HY-170498
CAS No.: 3076335-23-1
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABA-A Receptor Ligand-1 (Compound 4) is a ligand for GABA-A receptor with a pKi of 7.27. GABA-A Receptor Ligand-1 reduces mitochondrial dysfunction, promotes neurite outgrowth and neuronal regeneration. GABA-A Receptor Ligand-1 exhibits neuroprotective efficacy in rats ischemic stroke models .
loading...
    loading...
Cat. No.: HY-P5964
CAS No.: 2973365-72-7
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

K1 peptide is a high-affinity peptide ligand for GABAA receptor-associated protein (GABARAP) .
loading...
    loading...
Cat. No.: HY-105115
CAS No.: 111841-85-1
Synonyms: ZK 112119
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Abecarnil (ZK 112119) is a ligand or a partial agonist for benzodiazepine (BZ) receptor. Abecarnil possesses anxiolytic and anticonvulsant properties. Abecarnil can act as a positive allosteric modulator of GABAA receptor. Abecarnil inhibits the binding of the BZ [3H]lormetazepam to rat cerebral cortex membranes, with an IC50 of 0.82 nM. Abecarnil can be used for epilepsy research .
loading...
    loading...
Cat. No.: HY-103513
CAS No.: 1236105-75-1
Target:  

GABA Receptor

Research Areas:  

Others

GABAA receptor agent 2 (compound 13) is a compound used to study the structure and orthosteric ligand binding of GABA(A) receptors. The relevant model of GABAA receptor agent 2 can be used to understand the details of orthosteric ligand binding, and a detailed binding mode hypothesis was created through structure-activity relationships with two homologous series of orthosteric GABA(A)R antagonists.
loading...
    loading...
Cat. No.: HY-W013150R
CAS No.: 82626-01-5
Research Areas:  

Neurological Disease

Alpidem (Standard) is the analytical standard of Alpidem (HY-W013150). This product is intended for research and analytical applications. Alpidem, an anxiolytic agent, is an orally active and brain-penetrant GABAA receptor ligand, binds to α1β2γ2 subunit-containing GABAA receptors (IC50 of 17 nM) over α5β2γ2 subunit-containing GABAA receptors (IC50 of >10 μM). Alpidem modulates calcium-induced mitochondrial permeability transition, induces glutathione depletion and hepatocyte necrosis, potentiates TNF-α toxicity, inhibits marble-burying and locomotor activity, enhances stressed rodent feeding behavior, and exerts anticonvulsant effects. Alpidem can be used for the research of anxiety, anxiety disorders, and convulsions.
loading...
    loading...
Cat. No.: HY-W013150S
CAS No.: 1189962-23-9
Alpidem-d14 is the deuterium labeled Alpidem (HY-W013150) . Alpidem, an anxiolytic agent, is an orally active and brain-penetrant GABAA receptor ligand, binds to α1β2γ2 subunit-containing GABAA receptors (IC50 of 17 nM) over α5β2γ2 subunit-containing GABAA receptors (IC50 of >10 μM). Alpidem modulates calcium-induced mitochondrial permeability transition, induces glutathione depletion and hepatocyte necrosis, potentiates TNF-α toxicity, inhibits marble-burying and locomotor activity, enhances stressed rodent feeding behavior, and exerts anticonvulsant effects. Alpidem can be used for the research of anxiety, anxiety disorders, and convulsions.
loading...
    loading...
Cat. No.: HY-117560
CAS No.: 164025-33-6
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

PWZ-029 is a selective inverse agonist for 5 GABAA receptors. PWZ-029 is a benzodiazepine site ligand. PWZ-029 shows a weak but significant partial agonistic effect at 1- and 3-containing receptors. PWZ-029 significantly increases retention session latency in mouse fibroblast cells. PWZ-029 can improve object recognition in normal and scopolamine-treated rat model .
loading...
    loading...
Cat. No.: HY-117106
CAS No.: 200266-76-8
Target:  

GABA Receptor

Research Areas:  

Others

PNU-107484A is a GABAA receptor ligand that exhibits target activity mechanisms dependent on α isoforms. In the α1β2γ2 subtype, PNU-107484A acts as a positive allosteric modulator, enhancing GABA-induced Cl - currents, while it inhibits the currents in the α3β2γ2 and α6β2γ2 subtypes. The half-maximal concentrations for the α1β2γ2, α3β2γ2, and α6β2γ2 subtypes are 3.1, 4.2, and 3.5 μM, respectively. PNU-107484A can be used as a probe to investigate the physiological roles of different α isoform subtypes .
loading...
    loading...
Cat. No.: HY-189453
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

ETK-II-83 is an orally effective and blood-brain barrier-penetrant ligand for the benzodiazepine site of the GABAA receptor. ETK-II-83 displaces 3H-flunitrazepam from rat brain GABAA receptors and selectively binds to the α5-containing subtype. ETK-II-83 can be used for anxiety research .
loading...
    loading...